当前位置:首页 - 行情中心 - 复星医药(600196) - 财务分析 - 现金流量表

复星医药

(600196)

  

流通市值:674.10亿  总市值:849.73亿
流通股本:21.18亿   总股本:26.70亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金20,208,100,300.6410,133,330,424.1341,012,673,920.7530,140,941,020.19
  收到的税费返还184,554,340.7870,159,723.75481,786,382.91396,176,187.19
  收到其他与经营活动有关的现金996,338,870.54227,734,707.591,677,687,518.111,014,810,121.01
  经营活动现金流入小计21,388,993,511.9610,431,224,855.4743,172,147,821.7731,551,927,328.39
  购买商品、接受劳务支付的现金7,145,888,018.583,479,707,841.6615,087,001,072.3711,113,466,213.16
  支付给职工以及为职工支付的现金5,929,869,192.953,136,229,307.2111,060,190,509.888,472,222,959.74
  支付的各项税费1,464,706,738.36603,284,720.792,606,074,067.941,845,379,714.8
  支付其他与经营活动有关的现金4,714,529,067.762,156,323,107.369,941,900,909.367,134,221,085.52
  经营活动现金流出小计19,254,993,017.659,375,544,977.0238,695,166,559.5528,565,289,973.22
  经营活动产生的现金流量净额2,134,000,494.311,055,679,878.454,476,981,262.222,986,637,355.17
二、投资活动产生的现金流量:
  收回投资收到的现金1,625,743,729.781,070,446,951.42409,580,356.92334,148,666.4
  取得投资收益收到的现金134,793,660.8697,771,441.761,088,797,294.921,019,256,256.61
  处置固定资产、无形资产和其他长期资产收回的现金净额1,924,563.542,256,980.45457,808,960.28238,760,527.63
  处置子公司及其他营业单位收到的现金净额172,736,314.581,000,000131,424,365.62138,522,994.25
  收到的其他与投资活动有关的现金77,465,182.17103,848,787.75317,711,213.1193,073,923.23
  投资活动现金流入小计2,012,663,450.931,275,324,161.382,405,322,190.851,823,762,368.12
  购建固定资产、无形资产和其他长期资产支付的现金2,073,906,530.231,118,595,389.464,410,191,178.593,026,949,825.29
  投资支付的现金544,580,781.7774,571,745.98846,041,301.52931,718,461.75
  取得子公司及其他营业单位支付的现金--215,794,112.61-
  支付其他与投资活动有关的现金253,913,153.89267,248,411.34546,618,969.35304,806,549.95
  投资活动现金流出小计2,872,400,465.891,460,415,546.786,018,645,562.074,263,474,836.99
  投资活动产生的现金流量净额-859,737,014.96-185,091,385.4-3,613,323,371.22-2,439,712,468.87
三、筹资活动产生的现金流量:
  吸收投资收到的现金134,789,848.5777,763,335.05204,728,600.1168,075,471.89
  其中:子公司吸收少数股东投资收到的现金134,789,848.5777,763,335.05204,728,600.1168,075,471.89
  取得借款收到的现金16,192,026,243.136,496,493,638.7330,931,111,057.5121,739,468,572.59
  收到其他与筹资活动有关的现金521,751,778.55137,512,764.82,233,435,288.692,057,595,013.83
  筹资活动现金流入小计16,848,567,870.256,711,769,738.5833,369,274,946.323,965,139,058.31
  偿还债务支付的现金16,176,838,838.916,575,538,058.6230,520,787,294.3321,800,975,343.77
  分配股利、利润或偿付利息支付的现金777,894,219.56314,313,635.862,461,097,387.212,053,832,098.21
  其中:子公司支付给少数股东的股利、利润180,177,918.9112,494,331.81401,677,759.28354,336,577.14
  支付其他与筹资活动有关的现金1,354,035,085.6455,545,332.941,389,976,602.12612,621,029.02
  筹资活动现金流出小计18,308,768,144.077,345,397,027.4234,371,861,283.6624,467,428,471
  筹资活动产生的现金流量净额-1,460,200,273.82-633,627,288.84-1,002,586,337.36-502,289,412.69
四、汇率变动对现金及现金等价物的影响9,762,529.48,912,313.0327,989,327.43-69,635,970.14
五、现金及现金等价物净增加额-176,174,265.07245,873,517.24-110,939,118.93-25,000,496.53
  加:期初现金及现金等价物余额9,391,449,787.119,391,449,787.119,502,388,906.049,502,388,906.04
  期末现金及现金等价物余额9,215,275,522.049,637,323,304.359,391,449,787.119,477,388,409.51
补充资料:
  净利润2,100,210,564.8-3,512,440,385-
  资产减值准备64,269,906.34-96,569,884.79-
  固定资产和投资性房地产折旧773,788,060.53-1,543,138,675.38-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧773,788,060.53-1,543,138,675.38-
  无形资产摊销632,373,736.11-1,038,687,347.67-
  长期待摊费用摊销103,945,371.05-169,436,132.07-
  处置固定资产、无形资产和其他长期资产的损失-2,116,774.07--371,013,112.68-
  固定资产报废损失5,430,528.51-21,714,578.69-
  公允价值变动损失48,596,693.14-115,939,368.11-
  财务费用556,338,581.92-1,254,072,720.22-
  投资损失-2,120,176,697.39--2,104,607,405.87-
  递延所得税159,056,091.8--360,778,770.32-
  其中:递延所得税资产减少7,946,457.27--254,965,765.39-
    递延所得税负债增加151,109,634.53--105,813,004.93-
  存货的减少490,624,923.63-238,192,005.32-
  经营性应收项目的减少-421,230,400.73--397,523,060.54-
  经营性应付项目的增加-479,697,287.52--830,705,049.71-
  不涉及现金收支的投资和筹资活动金额其他项目--853,585,924.85-
  现金的期末余额9,215,275,522.04-9,391,449,787.11-
  减:现金的期初余额9,391,449,787.11-9,502,388,906.04-
  现金及现金等价物的净增加额-176,174,265.07--110,939,118.93-
公告日期2025-08-272025-04-302025-03-262024-10-30
审计意见(境内)标准无保留意见
TOP↑